Donepezil and Memantine for Moderate-to-Severe Alzheimer's DiseaseRobert Howard, Patrick Phillips, Rupert McShane et al.|New England Journal of Medicine|2012Cited by 774
Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analysesRobert Howard, Patrick Phillips, Rupert McShane et al.|The Lancet Neurology|2015Cited by 164
Cost‐effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO‐AD trial)Martín Knapp, Robert Howard, Renée Romeo et al.|International Journal of Geriatric Psychiatry|2016Cited by 63
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trialPatrick G. Kehoe, Bernadette McGuinness, Nicholas Turner et al.|The Lancet Neurology|2021Cited by 59
Does telecare prolong community living in dementia? A study protocol for a pragmatic, randomised controlled trialIracema Leroi, Craig Ritchie, Kirsty Forsyth et al.|Trials|2013Cited by 45